大学化学 >> 2025, Vol. 40 >> Issue (6): 145-159.doi: 10.12461/PKU.DXHX202406019

知识介绍 上一篇    下一篇

诱导程序性细胞死亡的金属抗肿瘤药物研究

曾家豪, 巢晖   

  1. 中山大学化学学院, 生物无机与合成化学教育部重点实验室, 广州 510006
  • 收稿日期:2024-06-11 录用日期:2024-09-02 发布日期:2025-06-20
  • 通讯作者: 巢晖 E-mail:ceschh@mail.sysu.edu.cn
  • 基金资助:
    国家自然科学基金(22120102002,92353301)

Research on Programmed Cell Death Induced by Metal Antitumor Drugs

Jiahao Zeng, Hui Chao   

  1. MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, China
  • Received:2024-06-11 Accepted:2024-09-02 Published:2025-06-20
  • Contact: CHAO Hui E-mail:ceschh@mail.sysu.edu.cn

摘要: 在生命体系中,细胞死亡是一个重要的过程,它涉及多种形式,这些死亡形式拥有不同的诱因、机制和特征。通过研究细胞各种死亡方式的分子机制,能够更好地干预并调控细胞死亡,这对癌症的治疗是极其重要的。自从顺铂被发现能够抑制癌细胞的增殖后,人们便开始重视并研究各类金属药物在抗肿瘤治疗中的作用。金属抗肿瘤药物诱导细胞死亡的方式是多样且复杂的,深入研究这些死亡方式有助于设计金属药物以诱导细胞发生特定形式的死亡,实现预期的治疗模式,达到理想的治疗效果。本文介绍了诱导细胞凋亡、坏死性凋亡、焦亡、铁死亡、铜死亡、胀亡和免疫原性死亡的金属药物及其近期研究进展。

关键词: 金属药物, 程序性细胞死亡, 抗肿瘤

Abstract: In biological systems, cell death represents a crucial biological process encompassing diverse modalities characterized by distinct triggers, molecular mechanisms, and phenotypic features. Elucidating the molecular pathways governing various cell death modalities enables targeted intervention and precise regulation of cellular demise, which holds paramount significance in cancer therapeutics. The discovery of cisplatin’s antiproliferative effects on cancer cells has catalyzed extensive investigation into metallic compounds for antitumor applications. The mechanisms through which metal-based antitumor agents induce cell death exhibit remarkable diversity and complexity. Systematic exploration of these death pathways facilitates the rational design of metallodrugs capable of triggering specific cell death modalities, thereby enabling tailored therapeutic strategies and optimized treatment outcomes. This review comprehensively summarizes recent advances in metal-based agents that induce apoptosis, necroptosis, pyroptosis, ferroptosis, cuproptosis, oncosis, and immunogenic cell death.

Key words: Metal drugs, Programmed cell death, Antitumor